Microchemical Journal, Год журнала: 2024, Номер unknown, С. 112482 - 112482
Опубликована: Дек. 1, 2024
Язык: Английский
Microchemical Journal, Год журнала: 2024, Номер unknown, С. 112482 - 112482
Опубликована: Дек. 1, 2024
Язык: Английский
Talanta, Год журнала: 2024, Номер 281, С. 126918 - 126918
Опубликована: Сен. 20, 2024
Язык: Английский
Процитировано
12Analytica Chimica Acta, Год журнала: 2025, Номер 1351, С. 343875 - 343875
Опубликована: Фев. 26, 2025
Язык: Английский
Процитировано
1ACS Omega, Год журнала: 2024, Номер 9(22), С. 23155 - 23171
Опубликована: Май 23, 2024
Ensuring a rapid and accurate identification of harmful bacteria is crucial in various fields including environmental monitoring, food safety, clinical diagnostics. Conventional detection methods often suffer from limitations such as long analysis time, complexity, the need for qualified personnel. Therefore, lot research effort devoted to developing technologies with potential revolutionize pathogenic by offering rapid, sensitive, user-friendly platforms point-of-care analysis. In this light, biosensors have gained significant commercial attention recent years due their simplicity, portability, capabilities. The purpose review identify trend analyzing which biosensor become commercially successful field detection. Moreover, we highlight characteristics that must possess finally arrive market therefore hands end-user, present critical examples applications technologies. aim investigate reason why certain achieved success extrapolate these trends future economic viability new subfield world biosensing: development biomimetic sensor platforms. an overview advances will be presented, after challenges addressed coming improve penetration critically evaluated. We zoom into current shortcomings sensors based on imprinting technology aptamers try come up recommendation further observed previous stories biosensing.
Язык: Английский
Процитировано
6Advanced Healthcare Materials, Год журнала: 2024, Номер unknown
Опубликована: Окт. 10, 2024
Over the past two decades, iron-based metal-organic frameworks (Fe-MOFs) have attracted significant research interest in biomedicine due to their low toxicity, tunable degradability, substantial drug loading capacity, versatile structures, and multimodal functionalities. Despite great potential, transition of Fe-MOFs-based composites from laboratory clinical products remains challenging. This review evaluates key properties that distinguish Fe-MOFs other MOFs highlights recent advances synthesis routes, surface engineering, shaping technologies. In particular, it focuses on applications biosensing, antimicrobial, anticancer therapies. addition, emphasizes need develop scalable, environmentally friendly, cost-effective production methods for additional meet specific requirements various biomedical applications. ability combine therapies, hurdles still remain, including a deeper understanding therapeutic mechanisms potential risks resistance overdose. Systematically addressing these challenges could significantly enhance prospects potentially facilitate integration into mainstream practice.
Язык: Английский
Процитировано
6Food Research International, Год журнала: 2024, Номер 191, С. 114727 - 114727
Опубликована: Июль 3, 2024
Язык: Английский
Процитировано
4Microchemical Journal, Год журнала: 2024, Номер unknown, С. 111736 - 111736
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
3Coordination Chemistry Reviews, Год журнала: 2025, Номер 533, С. 216538 - 216538
Опубликована: Фев. 21, 2025
Язык: Английский
Процитировано
0Polymer Bulletin, Год журнала: 2025, Номер unknown
Опубликована: Апрель 2, 2025
Язык: Английский
Процитировано
0Colloids and Surfaces B Biointerfaces, Год журнала: 2025, Номер 252, С. 114670 - 114670
Опубликована: Апрель 6, 2025
Язык: Английский
Процитировано
0Journal of Agricultural and Food Chemistry, Год журнала: 2025, Номер unknown
Опубликована: Май 24, 2025
The rapid detection of foodborne pathogens, such as Staphylococcus aureus and Salmonella, is critical for ensuring food safety. Herein, we present a magnetically controlled electrochemical biosensor integrating CRISPR/Cas12a with Fe3O4@Au nanoparticles designed to achieve ultrasensitive multiplexed detection. By utilization the magnetic separation CRISPR-cleaved ssDNA from nanoparticles, sensor circumvents intricate electrode modifications, enabling direct signal readout. This approach expedites workflow 65 min while achieving limit 2 CFU/mL. Additionally, exhibits stability over 45 days demonstrates its versatility by separate both Gram-positive (S. aureus) Gram-negative (Salmonella) pathogens. With validation in milk samples high interference resistance, this platform bridges CRISPR programmability practical deployability, offering robust solution on-site monitoring. innovation lies simplified design, enhanced stability, clinical versatility, setting new benchmark rapid, low-cost pathogen resource-limited environments.
Язык: Английский
Процитировано
0